Sign up for a free 30 day trial, find out more
Connell C - LB Mar 2022

FutureLife acquires The Centre for Reproductive and Genetic Health

The Centre for Reproductive and Genetic Health
Image from The Centre for Reproductive and Genetic Health’s website

FutureLife, a pan-European provider of IVF and related genetics services, backed by CVC Capital Partners and Hartenberg Holding, has acquired The Centre for Reproductive and Genetic Health (CRGH), an IVF clinic located in Central London.

CRGH is a large private fertility clinic located near Harley Street performing more than 3,200 egg collections a year. It was founded 30 years ago by current medical director Dr Paul Serhal.

FutureLife has more than 40 clinics that perform in excess of 40,000 IVF cycles annually, IVF add-on and laboratory services, as well as a series of biological and surgical treatments.

Earlier this year FutureLife attracted a new investor, private equity firm CVC, and is now focused on expanding its footprint in a number of key European regions, including the UK where it owns London-based City Fertility with which CRGH will operationally align.

Matěj Stejskal, chief executive and shareholder of FutureLife, said: “CRGH and the FutureLife group share the same culture, vision and principles in providing best-in-class care for our patients. The UK is an important strategic market for us and we look forward to growing our leading presence in this market through our partnership with CRGH. Our approach is based on harmonisation as we identify and share the best knowledge and medical practices across our platform, whilst ensuring that clinics maintain their strong clinical autonomy and brand. We look for partners that are able to help us grow our business further and bring excellence to our operations. CRGH had these parameters alongside and through exceptional people and we look forward to their joining the FutureLife group.”

Jozef Janov, managing partner at Hartenberg added: “The partnership with CRGH is another important milestone in FutureLife’s growth story in becoming a European leader in IVF. It will bring us additional know-how, clinical experience and excellence in the care provided to patients throughout our clinics.  It is also the first acquisition that we are completing with our new partners from CVC. Together with management, we remain focused on further acquisitions in the fragmented UK market.”

Cathrin Petty, managing partner at CVC, commented: “We are delighted that CRGH has chosen to partner with FutureLife.  This continues to deliver our strategy to build out the first-class FutureLife platform into new markets. Dr Serhal and his team are world-renowned for their clinical and scientific excellence and we will continue to invest behind them.”

Serhal added: “Partnering with FutureLife will support the strategic development of CRGH and build on our core values of clinical excellence, success through continual innovation, and bespoke patient care. The growing FutureLife community provides breadth and depth of leadership in IVF and I look forward to the next chapter of this exciting journey.”

Jonathon Lawrence, who will lead the combined operations of CRGH and City Fertility as FutureLife’s chief executive of UK, commented: “This partnership gives us the foundation to build on the success of CRGH in the UK as part of the FutureLife family. I look forward to leading this new joint venture through a period of strong, sustained growth.”

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login

Talk to our team

Zina Fragkiadaki 0207 451 7058 Editor

Caroline Bowern 0797 4643292 Advertising and sales manager